COPPER
COPPER
COPPER
40
32
total serum copper (umol/L)
24
normal range
16
0
WD aCAH PSC CLD LF AH no LD
Caeruloplasmin in children with liver disease
0.75
0.60
caeruloplasmin (g/L)
0.45
normal range
0.30
0.15
0
WD aCAH PSC CLD LF AH no LD
Non-caeruloplasmin bound
copper
In conditions of copper excess there is an increase
in non-caeruloplasmin bound - ‘free’ copper.
15
serum free copper (umol/L)
12
0
W aCAH PSC CLD LF AH no LD
D
Urine copper
30
urine copper (umol/24h)
20
10
80
60
urine copper (umol/24 h)
40
20
3000
Liver copper (ug/g dry wt)
2400
1800
1200
600
Wilson’s Others
Typical results
Normal Wilson's
disease
Fulminant Non-fulminant Heterozygotes
Serum Cu 12-25 14.7 5.0 8.2
(umol/L)
Caeruloplasmin 0.2-0.45 0.11 0.08 0.17
(g/L)
Urine Cu - Pre <1.2 34 3.2 0.6
(umol/24h)
- Post <25 43 32.6 8.4
Liver Cu 20-50 880 250 103
(ug/g dry wt)
Sensitivity and specificity of tests
for Wilson’s disease
Sensitivity Specificity
% %
Caeruloplasmin 82.4 94.4
Serum copper 56.3 94.2
Urine copper 100 82.8
- Pre
Urine copper 88.2 98.2
- Post
Liver copper 75.0 61.5
Wilson’s disease gene
Wilson disease is inherited as an autosomal
recessive disease.
The gene has been located on chromosome 13
occupying 80 kb and encoding a 7.5 kb product
There is significant sequence homology (54%) with
the gene causing Menke’s disease.
The product is an ATP-dependent copper-
transporting protein (not caeruloplasmin) involved
in cellular regulation of copper.
ATP7b gene
Gene mutations
Large study involving cases from US, Russia, Sicily,
Sweden and Costa Rica (Am J Hum Genet 61 317-28 1997)
27 distinct mutations found. Compound heterozygotes
common. New mutations are continually being found (>75).
Commonest His1069Glu was represented in 38% of WD
from US, Russia and Sweden
In the Costa Ricans Asn1270Ser represented 61% of
mutations.
No obvious genotype-phenotype correlations
Treatment and monitoring
Penicillamine - Urine excretion on and
Trientine off therapy
Zinc - Urine copper not helpful